Authors:
BEVERIDGE R
SCHUSTER M
WALLER E
STUART R
ABBOUD C
CRUICKSHANK S
MENCHACA D
MACRI M
CONNAGHAN DG
Citation: R. Beveridge et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 90(10), 1997, pp. 2580-2580
Authors:
CRAIG JR
BAIN VG
BLACK M
CRUICKSHANK S
EHRINPREIS M
FOUST R
HOFLING D
LEE W
SAROSI I
SMITH CI
VANLEEUWEN DJ
Citation: Jr. Craig et al., LIVER HISTOLOGY IMPROVEMENT IS ASSOCIATED WITH ALT AND HCV RNA RESPONSE FOLLOWING TREATMENT WITH CONSENSUS INTERFERON (CIFN), Gastroenterology, 110(4), 1996, pp. 1175-1175
Authors:
MAHER DW
LIESCHKE GJ
GREEN M
BISHOP J
STUARTHARRIS R
WOLF M
SHERIDAN WP
KEFFORD RF
CEBON J
OLVER I
MCKENDRICK J
TONER G
BRADSTOCK K
LIESCHKE M
CRUICKSHANK S
TOMITA DK
HOFFMAN EW
FOX RM
MORSTYN G
Citation: Dw. Maher et al., FILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(7), 1994, pp. 492-501